Literature DB >> 15128350

Lack of evidence of sexual transmission of hepatitis C among monogamous couples: results of a 10-year prospective follow-up study.

Carmen Vandelli1, Francesco Renzo, Luisa Romanò, Sergio Tisminetzky, Marisa De Palma, Tommaso Stroffolini, Ezio Ventura, Alessandro Zanetti.   

Abstract

The risk of sexual transmission of hepatitis C virus (HCV) infection was evaluated among 895 monogamous heterosexual partners of HCV chronically infected individuals in a long-term prospective study, which provided a follow-up period of 8,060 person-years. Seven hundred and seventy-six (86.7%) spouses were followed for 10 yr, corresponding to 7,760 person-years of observation. One hundred and nineteen (13.3%) spouses (69 whose infected partners cleared the virus following treatment and 50 who ended their relationship or were lost at follow-up) contributed an additional 300 person-years. All couples denied practicing anal intercourse or sex during menstruation, as well as condom use. The average weekly rate of sexual intercourse was 1.8. Three HCV infections were observed during follow-up corresponding to an incidence rate of 0.37 per 1,000 person-years. However, the infecting HCV genotype in one spouse (2a) was different from that of the partner (1b), clearly excluding sexual transmission. The remaining two couples had concordant genotypes, but sequence analysis of the NS5b region of the HCV genome, coupled with phylogenetic analysis showed that the corresponding partners carried different viral isolates, again excluding the possibility of intraspousal transmission of HCV. Our data indicate that the risk of sexual transmission of HCV within heterosexual monogamous couples is extremely low or even null. No general recommendations for condom use seem required for individuals in monogamous partnerships with HCV-infected partners.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15128350     DOI: 10.1111/j.1572-0241.2004.04150.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  69 in total

Review 1.  Updating the management of sexually transmitted infections.

Authors:  Catriona Ooi; David Lewis
Journal:  Aust Prescr       Date:  2015-12-01

Review 2.  Management of patients coinfected with HCV and HIV: a close look at the role for direct-acting antivirals.

Authors:  Susanna Naggie; Mark S Sulkowski
Journal:  Gastroenterology       Date:  2012-05       Impact factor: 22.682

3.  Hepatitis-C prevalence in an urban native-American clinic: a prospective screening study.

Authors:  Amy S Neumeister; LaVada E Pilcher; Judi M Erickson; Lora L Langley; Mary M Murphy; Nicole M Haukaas; Mark E Mailliard; Jennifer L Larsen
Journal:  J Natl Med Assoc       Date:  2007-04       Impact factor: 1.798

4.  Epidemiological characteristics and medical follow-up of 61 patients with acute hepatitis C identified through the hepatitis C surveillance system in France.

Authors:  C Brouard; P Pradat; E Delarocque-Astagneau; C Silvain
Journal:  Epidemiol Infect       Date:  2007-08-16       Impact factor: 2.451

Review 5.  Acute hepatitis C virus infection: a chronic problem.

Authors:  Jason T Blackard; M Tarek Shata; Norah J Shire; Kenneth E Sherman
Journal:  Hepatology       Date:  2008-01       Impact factor: 17.425

6.  Self-reported hepatitis C virus antibody status and risk behavior in young injectors.

Authors:  Holly Hagan; Jennifer Campbell; Hanne Thiede; Steffanie Strathdee; Lawrence Ouellet; Farzana Kapadia; Sharon Hudson; Richard S Garfein
Journal:  Public Health Rep       Date:  2006 Nov-Dec       Impact factor: 2.792

7.  Sexually transmitted diseases treatment guidelines, 2015.

Authors:  Kimberly A Workowski; Gail A Bolan
Journal:  MMWR Recomm Rep       Date:  2015-06-05

8.  Sexual transmission of hepatitis C: A rare event among heterosexual couples.

Authors:  Jennifer L Dodge; Norah A Terrault
Journal:  J Coagul Disord       Date:  2014-03

9.  Risky sexual behavior, bleeding caused by intimate partner violence, and hepatitis C virus infection in patients of a sexually transmitted disease clinic.

Authors:  Marcia Russell; Meng-Jinn Chen; Thomas H Nochajski; Maria Testa; Scott J Zimmerman; Patricia S Hughes
Journal:  Am J Public Health       Date:  2009-02-12       Impact factor: 9.308

10.  Injection drug use is a risk factor for HCV infection in urban Egypt.

Authors:  Adela Paez Jimenez; Mostafa K Mohamed; Noha Sharaf Eldin; Hasnaa Abou Seif; Said El Aidi; Yehia Sultan; Nasr Elsaid; Claire Rekacewicz; Mostafa El-Hoseiny; May El-Daly; Mohamed Abdel-Hamid; Arnaud Fontanet
Journal:  PLoS One       Date:  2009-09-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.